REG - Cambridge Cognition - Notice of AGM

Cambridge Cognition HoldingsAnnouncement

06/06/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240606:nRSF3232Ra&default-theme=true

RNS Number : 3232R  Cambridge Cognition Holdings PLC  06 June 2024

 

Cambridge Cognition Holdings plc

("Cambridge Cognition" or the "Company")

 

 

Posting of Annual Report & Notice of AGM

 

 

Cambridge Cognition (AIM:COG), which develops and markets digital solutions to
assess brain health, confirms that the Annual Report and Accounts for the year
ended 31 December 2023 ("2023 Annual Report and Accounts") and the Notice of
the Annual General Meeting ("AGM") will be published on the Company's website
today www.cambridgecognition.com
(file:///C:/Users/Emma/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/PU3P4A8W/www.cambridgecognition.com)
. Hard copies have been posted to those shareholders who requested them.

 

The AGM is to be held at 9:00am on 28 June 2024 at the registered office of
the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25
9TU.

 

 

 

 

Enquiries:

 

 Cambridge Cognition Holdings plc                        Tel: 012 2381 0700
 Matthew Stork, Chief Executive Officer
 Stephen Symonds, Chief Financial Officer

 Panmure Gordon (UK) Limited (NOMAD & Joint Broker)      Tel: 020 7886 2968
 Freddy Crossley / Emma Earl / Mark Rogers               (Corporate Finance)
 Rupert Dearden                                          (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)                  Tel: 020 3903 7715
 David Poutney / James Serjeant

 Hudson Sandler (Financial PR and IR)                    Tel: 020 7796 4133

 Dan de Belder / Hattie Dreyfus                          cog@hudsonsandler.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAQKPBDDBKBPAK